Dr. Sameer Thapar is Oracle Health Science’s Director of Global Pharmacovigilance and is currently on faculty as professor for the drug safety and pharmacovigilance track of the Masters in Clinical Trial Sciences program at Rutgers University. Dr. Thapar holds a doctorate of pharmacy and has extensive experience in operations within the pharmaceutical, biotech, and CRO industries, with cross-functional experience in medical, clinical, quality, and subject matter expertise in pharmacovigilance (PV) operations and compliance. He has built global PV departments and defended in successful FDA, MHRA, and EMA health authority inspections. He is an active as a speaker and panelist in numerous industry conferences. He is well versed in a multitude of therapeutic areas and PV-related databases. Dr. Thapar was previously chief principal in MedEsq LLC, a pharmacovigilance and risk management consulting firm and is currently on faculty as professor for the drug safety and pharmacovigilance track.